1. Home
  2. FDMT vs CLDT Comparison

FDMT vs CLDT Comparison

Compare FDMT & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$10.21

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Logo Chatham Lodging Trust (REIT) of Beneficial Interest

CLDT

Chatham Lodging Trust (REIT) of Beneficial Interest

N/A

Current Price

$15.36

Market Cap

660.3M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
FDMT
CLDT
Founded
2013
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
695.3M
660.3M
IPO Year
2019
2009

Fundamental Metrics

Financial Performance
Metric
FDMT
CLDT
Price
$10.21
$15.36
Analyst Decision
Strong Buy
Buy
Analyst Count
12
4
Target Price
★ $28.09
$16.17
AVG Volume (30 Days)
★ 855.5K
444.7K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
★ 2.58%
EPS Growth
18.79
★ 275.00
EPS
N/A
★ 0.11
Revenue
$85,209,000.00
★ $295,075,000.00
Revenue This Year
N/A
$9.69
Revenue Next Year
$20.79
$3.41
P/E Ratio
★ N/A
$140.64
Revenue Growth
★ 230194.60
N/A
52 Week Low
$6.96
$6.41
52 Week High
$16.93
$16.61

Technical Indicators

Market Signals
Indicator
FDMT
CLDT
Relative Strength Index (RSI) 37.51 53.94
Support Level $8.43 $12.36
Resistance Level $10.61 $16.61
Average True Range (ATR) 0.85 0.57
MACD -0.15 -0.08
Stochastic Oscillator 1.07 32.97

Price Performance

Historical Comparison
FDMT
CLDT

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest

Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.

Share on Social Networks: